These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32464173)

  • 1. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
    Lee C; Willerth SM; Nygaard HB
    Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
    Riemens RJM; Kenis G; van den Beucken T
    Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modeling familial Alzheimer's disease with induced pluripotent stem cells].
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Okano H; Suzuki N
    Rinsho Shinkeigaku; 2012; 52(11):1134-6. PubMed ID: 23196540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived iPSCs, a reliable
    Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
    Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
    Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
    Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Three-Dimensional Alzheimer's Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1.
    Hernández-Sapiéns MA; Reza-Zaldívar EE; Cevallos RR; Márquez-Aguirre AL; Gazarian K; Canales-Aguirre AA
    Front Cell Neurosci; 2020; 14():151. PubMed ID: 32655369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Alzheimer's disease with iPSC-derived brain cells.
    Penney J; Ralvenius WT; Tsai LH
    Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
    Si Z; Wang X
    J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
    Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.
    Nair M; Sandhu SS; Sharma AK
    Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish.
    Tong G; Izquierdo P; Raashid RA
    Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.